or Try an Advanced Search...

    Treatment Of Alzheimer's Disease Stocks List

    Symbol Grade Name % Change
    AVXL A Anavex Life Sciences Corp. 3.25
    NRSNW D NeuroSense Therapeutics Ltd. - warrant 0.00
    VTVT D vTv Therapeutics Inc. 2.29
    PRTA F Prothena Corporation plc -2.06
    ACAD F ACADIA Pharmaceuticals Inc. 1.51
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Alzheimer's Disease Parkinson's Disease Biopharmaceutical Amyotrophic Lateral Sclerosis Chemical Compounds Disease Lewy Body Dementia Neurological Disorders Neuroscience Treatment Of Parkinson's Disease Aging Associated Diseases Alpha Synuclein Amyloid Antibodies Autoimmune Disease Biology Biotechnology Biotie Therapies Buparlisib Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Alzheimer's Disease stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 5.37
    AWEG B Alger Weatherbie Enduring Growth ETF 3.41
    FBT A First Trust Amex Biotech Index Fund 3.31
    PBE C PowerShares Dynamic Biotech & Genome 2.62
    SBIO B ALPS Medical Breakthroughs ETF 2.44
    View all Treatment Of Alzheimer's Disease ETFs...
    Compare ETFs
    Compare AWEG to SBIO Compare IBRN to PBE Compare IBRN to SBIO

        Treatment Of Alzheimer's Disease Stocks Recent News

        Date Stock Title
        Oct 31 ACAD ACADIA Pharmaceuticals Inc (ACAD): Worst-Performing Growth Stock in 2024
        Oct 31 AVXL Anavex gains as lead asset slows Alzheimer’s disease progression by a third
        Oct 31 AVXL Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
        Oct 29 PRTA Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock?
        Oct 29 PRTA Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength?
        Oct 28 PRTA PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
        Oct 28 NRSNW NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
        Oct 28 NRSNW EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
        Oct 26 VTVT vTv Therapeutics Faces License Agreement Termination
        Related Industries: Biotechnology
        Related Stock Lists: Alzheimer's Disease Parkinson's Disease Biopharmaceutical Amyotrophic Lateral Sclerosis Chemical Compounds Disease Lewy Body Dementia Neurological Disorders Neuroscience Treatment Of Parkinson's Disease Aging Associated Diseases Alpha Synuclein Amyloid Antibodies Autoimmune Disease Biology Biotechnology Biotie Therapies Buparlisib Cancer
        Treatment Of Alzheimer's Disease

        Treatment of Alzheimer's disease is focused on managing symptoms and slowing the progression of the disease. Treatment typically involves a combination of medications, lifestyle changes, and supportive care. Medications used to treat Alzheimer's disease include cholinesterase inhibitors, memantine, and other medications to manage behavioral symptoms. Lifestyle changes may include exercise, cognitive stimulation, and social activities. Supportive care may include counseling, respite care, and other services to help caregivers manage the demands of caring for someone with Alzheimer's disease.

        Browse All Tags